the first aspect one has to understand is it is non retail

New Post Public Reply Private Reply Replies (1) Message Board
4kids scgmck1 #51470
488
the first aspect one has to understand is it is non retail that reports to Finra

they are (for the most part) self regulating entities (fox/henhouse comes to mind) .. and it's why i like to point out the clearly *false* and bogus bs that gets *reported* by NR .. particularly when it's so egregious (that is why I took the time to show IPIX YTD *volume* running 10M~ *less* @ the EO August 2018 as compared to EO August 2017 and noted in early September that NR would have to address that *issue* and it was .. with a vengeance .. 33M~ for the first 9 months' total of 2018 vs 29M~ for September and October 2018) .. it is also why I did the post showing what NR reported re: the *legal* since CTIX/IPIX first began to trade and revealed *imo* NRs' comfort zone re: reporting *legal* (800k - 850k) and when NR showed *stress* (after cusip change out and mid summer 2018 see below) and when imo NR was working cycles of money (taking PPS up and down .. 2012/2013/2014)

having spent a good part of February 2009 on the phone with Finra (daily reg sho link went live) .. I learned among other things that any MM can be shown on Bid or Ask .. but only those MMs/ECNs who actually do the *activity* .. can report that volume to Finra for the month (MM Monthly is unique to the OTC) .. that is why for example on IPIX for the past few years .. there are really only 3 MMs that matter where showing .. (CDEL/ETRF/NITE) .. and odds are that is also why when one sees say VERT/VNDM/LAFC *blocking/showing* on either Bid or Ask for most of the month .. yet only does a fraction of the Monthly Volume Total .. odds are VERT/VNDM/LAFC is a decoy for one of the 3 noted above

watching the ask side .. i tend to note position 5 .. today was interesting in that a few times .. the usual for weeks on end of 23c .. was relo/d to 35c .. as i've noted numerous times .. no one does smoke and mirrors better than NR .. but rarely does the ask side *adjust* significantly when NR is controlling as *imo* they have been at every turn since pattern change out re: *volume* on 9.12.18 ..

one grab today .. IPIX ask

NITE 0.1399 11,000 11:58
CDEL 0.1399 5,000 11:58
OTCX 0.14 6,500 11:40
VNDM 0.23 2,500 11/27
LAFC 0.35 2,500 11/19


today was clearly a *volume* day for IPIX (this is usually when i post out the tape of trades and some today were fascinating size wise for those of us who sat on bid for days getting bypassed weeks' back with a size far smaller showing then)

but what i've been watching for for a few months now is seeing the volume avgs increase .. when NR did the *imo* handoff of late 2014 (run up) into 2015 (reset down) .. CTIX's volume avgs were on avg running in the 500k to 600k range (price point was a hell of a lot higher in 2015 than in 2018) .. so for example ..

here's the avgs for IPIX back in July when NR *reported* their record legal high of 1.5M~
and note the *liquidity range in relation to daily volume engendered*

07/13/2018 Innovation Pharma IPIX 1,529,297 1,338,448 190,849 14.26 427,129 3.58


Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.57Up 0.05 (9.62 %)AS OF 3:59:58PM ET 07/13/2018


Last Trade 0.57
Trade Time 3:59:58pm ET

Change 0.05
% Change 9.62%


Bid 0.55
Bid Size 1000

Ask 0.57
Ask Size 1000


Open 0.52
Day High 0.575 ** .055c *liquidity*
Day Low 0.52
Previous Close
07/12/2018 0.52

52-Week High
12/06/2017 1.17

52-Week Low
06/21/2018 0.325


Price Performance (Last 52 Weeks)
07/12/2018 -48.00%


Volume 188,605
Volume (10 day Average) 354,333
Volume (90 day Average) 222,768


last grab B/A .. on 7.13.18

CDEL 0.56 1,925 15:58
NITE 0.55 3,318 15:56
VERT 0.54 1,000 15:40
ETRF 0.53 4,000 15:34
OTCX 0.5016 2,500 15:40
CSTI 0.5016 2,500 13:43
LAFC 0.3975 2,500 10:25
STXG 0.30 2,500 04/17
VNDM 0.30 2,500 07/12
PUMA 0.25 2,500 08:10
CANT 0.1101 5,000 08:30
MAXM 0.0001 10,000 07:35
DBOX U 0 04/16

VERT 0.57 1,000 15:58
CDEL 0.58 5,000 15:58
CSTI 0.58 1,000 15:34
OTCX 0.5875 2,000 10:07
ETRF 0.588 4,200 15:47
LAFC 0.608 1,000 07/09
VNDM 0.64 1,000 07/12
CANT 0.64 1,000 08:30
NITE 0.70 1,000 15:39
PUMA 1.00 100 08:10
STXG 2.00 100 10/05
MAXM 8.00 100 07:35
DBOX U 0 04/16



and here's today's avgs .. and YOY -%


Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.133Up 0.001 (0.76 %)AS OF 3:59:44PM ET 11/28/2018


Last Trade 0.133
Trade Time 3:59:44pm ET

Change 0.001
% Change 0.76%


Bid 0.13
Bid Size 5000

Ask 0.14
Ask Size 5000


Open 0.1325
Day High 0.15 ** .0212c *liquidity*
Day Low 0.1288
Previous Close
11/27/2018 0.132

52-Week High
12/06/2017 1.17

52-Week Low
11/20/2018 0.1025


Price Performance (Last 52 Weeks)
11/27/2018 -82.22%


Volume 875,275
Volume (10 day Average) 550,118
Volume (90 day Average) 503,775


last grab B/A today ..

ETRF 0.13 5,000 15:07
NITE 0.125 12,000 15:22
CDEL 0.125 8,000 15:54
VERT 0.11 5,000 11/23
VNDM 0.102 5,000 11/27
STXG 0.1012 5,000 09/28
LAFC 0.1012 5,000 11/19
PUMA 0.10 5,000 08:10
CSTI 0.10 5,000 15:22
MICA 0.001 10,000 13:28
MAXM 0.0001 10,000 07:35
CANT 0.0001 10,000 11:33
INTL U 0 10/24
DBOX U 0 07:45
OTCX U 0 08:15

NITE 0.14 21,000 15:54
CDEL 0.14 5,000 15:54
CSTI 0.18 5,000 15:22
VNDM 0.23 2,500 11/27
LAFC 0.35 2,500 11/19
VERT 0.35 2,500 11/23
PUMA 0.35 2,500 08:10
CANT 0.36 5,000 09:30
ETRF 0.565 2,000 14:58
STXG 2.00 100 >year
MAXM 8.00 100 07:35
MICA 12.00 100 13:28
INTL U 0 10/24
DBOX U 0 07:45
OTCX U 0 15:53


to me pattern change outs are always worth noting ..

i've maintained that usually NR only gets retail to sell by taking a stock high enough .. or so low emotions get played by relentless pps compression (usually in conjunction with multi/s repetitive FUD bombarding SMBs) .. imo NR took CTIX/IPIX too low which imo essentially drove out retail traders and the liquidity traders' provided .. making NRs' hole progressively more deep on less and less *volume* ..

that didn't leave NR with too many alternatives imo .. a need to create volume and a pps cycle to entice traders and build that volume base back up (cushion) for mgmt filings/updates .. but also try to keep the pps so tightly constrained as to not lose control to legitimate demand (vs the washed kind done by those who illegally manipulate OTC targets by rote) ... and to be clear imo NR has had leeway to take IPIX up if so inclined .. (they got zooey months' back when YOY -%s dipped into low 30s) .. it's now in the mid -80s and has been for a while .. with very little by way of pps *take up*

and while mgmt's clock continues to tick down .. and retail investors continue to pick off and add IPIX *shares* .. NR reports erroneous *daily volume* avgs when they *report* their legal short position .. makes me wonder if inverted let alone accurate .. my bet is it is not remotely accurate and my expectation has been that IPIX will trigger reg sho with mgmt's execution

4kids
Quote:

4kids, would you mind breaking this down for some of us. I'm not sure I understand all of this. Obviously, our daily avg isn't 1.2 mm shares or 1.4 for that matter. Where did FINRA get that number from?













Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Fangzhou Achieves National High-Tech Status Amid Innovation Surge

Updated Category News Views 417

Fangzhou Recognized as a 2024 National High-Tech Enterprise Beijing Fangyixing Information Technology Co., Ltd. has received the prestigious National High-Tech Enterprise certification for 2024. This endorsement highlights its innovative strides within the AI-driven healthcare sector. The recognition, awarded by key governmental bodies, is a testament to Fangyixing's...

Continue Reading
Ardagh Group Announces Departure of CFO John Sheehan

Updated Category News Views 168

Ardagh Group Announces Transition in Leadership In a significant development for Ardagh Group S.A., John Sheehan will step down from his position as Group CFO as the year concludes. This announcement came after discussions with the Board earlier in the year, marking a planned transition as the company prepares for future opportunities. Gratitude for Contributions Mark...

Continue Reading
Massive Viewership for Sean Hannity's Trump Musk Interview

Updated Category News Views 409

Sean Hannity's Stunning Interview Achieves Record Viewership During a significant television event, Sean Hannity's exclusive interview with President Donald Trump and Elon Musk drew an impressive audience of 5.4 million viewers. This remarkable session not only outperformed competing shows in its time slot but also represented a significant increase in engagement compared...

Continue Reading
Ourself Launches Innovative Serum to Brighten Complexion

Updated Category News Views 297

Introducing the Complexion Brightening Serum Ourself has made significant strides in skincare innovation with the launch of its new Complexion Brightening Serum, designed specifically to combat skin discoloration. This innovative product is clinically proven to visibly reduce discoloration and plays a vital role in preventing future pigment formation, marking a major leap...

Continue Reading
ISS A/S Steps Up with Share Buyback Initiative in 2025

Updated Category News Views 182

ISS A/S Unveils Share Buyback Program to Enhance Shareholder Value In an exciting development for investors, ISS A/S, a prominent player in the workplace experience and facility management sector, has initiated a share buyback program aimed at redistributing excess cash to its shareholders. The announcement came on a notable date earlier in the year, marking a strategic...

Continue Reading